Phase II Study of Weekly Oxaliplatin With Continous Infusion Fluorouracil And Concurrent Radiation for Treatment of Localised Oesophageal Carcinoma
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi-Synthelabo
- 08 Jun 2016 Status changed from recruiting to completed.
- 14 Jan 2009 New trial record.